Shenzhen - Delayed Quote CNY
Newland Pharmaceutical Co., Ltd. (301277.SZ)
11.81
-0.69
(-5.52%)
At close: 3:04:16 PM GMT+8
Breakdown
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Assets
1,813,734.23
1,609,505.73
1,533,773
667,902.38
Total Liabilities Net Minority Interest
270,690.83
160,016.76
174,582.74
261,526.28
Total Equity Gross Minority Interest
1,543,043.40
1,449,488.97
1,359,190.27
406,376.10
Total Capitalization
1,542,189.23
1,448,017.46
1,355,941.51
432,923
Common Stock Equity
1,542,189.23
1,448,017.46
1,355,941.51
402,530.59
Capital Lease Obligations
2,250.99
727.44
2,881.49
--
Net Tangible Assets
1,505,370.53
1,409,933.88
1,317,167.80
362,822.08
Working Capital
978,241.88
1,017,177.71
1,031,095.82
180,426.99
Invested Capital
1,542,919.20
1,448,017.46
1,355,941.51
524,249.85
Tangible Book Value
1,505,370.53
1,409,933.88
1,317,167.80
362,822.08
Total Debt
2,980.96
2,718.56
5,721.39
126,379.26
Net Debt
--
--
--
87,506.99
Share Issued
392,078.40
392,078.40
392,078.40
294,000
Ordinary Shares Number
392,078.40
392,078.40
392,078.40
294,000
12/31/2021 - 11/16/2022
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade